Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

$300M research fund will focus on Alzheimer’s

The research fund aims to track the health of Americans for decades, with the intent of housing the long-term health information of 70% to 90% of the population.

ChatGPT chatbot

Liver specialists among first to be ably aided by ChatGPT

ChatGPT isn’t capable of unilaterally guiding care for patients with cirrhosis or the liver cancer it tends to spawn, hepatocellular carcinoma (HCC). However, the large-language AI tool can competently assist clinicians.  

Thumbnail

Illumina ordered to divest Grail

The agency, which is charged with preventing fraud, deception and unfair business practices, said Illumina’s acquisition of Grail would stifle competition and innovation in the U.S. market for life-saving cancer tests.

FDA turns up sterility issues at eye drop facility linked to deaths, vision loss

The FDA has found a drug-resistant bacteria at an eye drop manufacturing facility linked to severe infections and even a few deaths.

Thumbnail

Affordable Care Act dealt a blow in new judgment

The Affordable Care Act (ACA) was dealt a major blow after a federal judge ruled that employers don’t have to cover certain preventive services, including PReP, which prevents HIV.

Telehealth use plummets after pandemic highs

Use of the telehealth soared in 2020, but utilization has since fallen off a cliff after changing conditions of the COVID-19 pandemic. 

Microsoft Johns Hopkins AI partnership

7 lessons learned during joint big business/healthcare AI projects

Big Tech players have been investing in partnerships with large healthcare providers on AI endeavors for several years now. According to both sides in one such collaboration, the resulting synergy offers “immense potential” to improve patient access, care and outcomes.

Johnson & Johnson scraps RSV vaccine after trial

The move comes as RSV has been on the rise in the United States.